Responsiveness of an activity tracker as a measurement tool in a knee osteoarthritis clinical trial (ACTIVe-OA study) - 25/08/22
, Manuela L. Ferreira a, Vicky Duong a, Jimmy Caroupapoullé b, Nigel K. Arden c, d, Kim L. Bennell e, David J. Hunter a
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | This is the first osteoarthritis clinical trial to utilise activity tracker-recorded outcomes. |
• | Activity trackers are a feasible measurement tool in a clinical trial context. |
• | Behavioural and physical activity change was observed via step count and load rate. |
• | Activity tracker-recorded outcomes did not show significant responsiveness or validity. |
Abstract |
Background |
In osteoarthritis (OA) clinical trials, reliable and responsive outcome measures to document physical and functional improvements are limited.
Objective |
This study aimed to assess whether the use of an activity tracker in an OA clinical trial is a responsive measurement tool. Secondary objectives assessed feasibility and validity.
Methods |
We recruited 65 participants in a prospective cohort study nested in a placebo-controlled clinical trial of platelet-rich plasma injection in knee OA. Participants wore an activity tracker (Fitbit Flex 2), and a smartphone was preloaded with a mobile application (OApp) designed to monitor load rates as a surrogate of knee loading. Participants used the systems for 7 days at baseline and for 7 days before the 2-month follow-up assessment. Effect size (ES) and standardised response mean (SRM) were calculated for change in step count and knee loading rate and regularly used knee OA outcome measures. Correlation coefficients (r) were calculated to examine the strength of the association between outcome measures.
Results |
. Step count showed a trivial ES and SRM and mean knee loading rate measurements a moderate ES and SRM. We found a weak but significant correlation between change in mean steps per day and global improvement overall (r= 0.28) and Western Ontario and McMaster Universities Osteoarthritis Index function (r = -0.28). Compliance was high with the activity trackers.
Conclusions |
Despite good feasibility, this study did not show significant responsiveness or validity of the activity trackers as compared with currently recommended outcome measures in OA clinical trials. The main challenge is the lack of a gold standard outcome measure to validate against, and because of the complex interplay between pain and measured function, a lack of correlation does not necessarily represent a failed validation in this context.
Australian New Zealand Clinical Trials Registry |
ACTRN12617000853347. This trial is a substudy of the “Platelet-rich plasma as a symptom-and disease-modifying treatment for knee osteoarthritis – the RESTORE trial”.
Le texte complet de cet article est disponible en PDF.Keywords : Osteoarthritis, Fitness trackers, Activity trackers, Smartphones, Outcome assessment
Plan
Vol 65 - N° 5
Article 101619- septembre 2022 Retour au numéro
Article précédent
- Prognostic value of the five-repetition sit-to-stand test for mortality in people with chronic obstructive pulmonary disease
- Francesc Medina-Mirapeix, Elisa Valera-Novella, Jaume Morera-Balaguer, Roberto Bernabeu-Mora
- Carbapenemase-producing Enterobacteriaceae in an inpatient post-acute care facility: Impact on time to functional recovery
- Noureddine Henoun Loukili, Jean-François Jusot, Etienne Allart, Gael Celani, Agnes Perrin, Olivier Gaillot, Anne Blanchard, Vinciane Pardessus, André Thevenon, Vincent Tiffreau
Bienvenue sur EM-consulte, la référence des professionnels de santé.